Smart Nanocarriers as an Emerging Platform for Cancer Therapy: A Review

Area of Science:

• Oncology
• Nanotechnology
• Materials Science

Background:

• Cancer, a disease of uncontrolled cell growth affecting millions globally, necessitates innovative therapeutic strategies.
• Nanocarrier systems show significant promise in cancer imaging, diagnostics, and therapeutics, enhancing treatment efficacy.
• Developing smart nanocarriers that respond to cancer-specific conditions is crucial for targeted drug delivery.

Purpose of the Study:

• To review current advancements in smart nanocarriers for cancer therapy.
• To discuss various types of nanocarriers, including dendrimers, liposomes, and nanoparticles.
• To explore targeted drug delivery mechanisms and stimuli-responsive nanotherapeutics.

Main Methods:

• Review of current literature on nanocarrier-based cancer therapeutics.
• Analysis of different nanocarrier platforms such as dendrimers, liposomes, mesoporous silica nanoparticles, quantum dots, micelles, superparamagnetic iron-oxide nanoparticles, gold nanoparticles, and carbon nanotubes.
• Discussion of targeting strategies and stimuli-responsive mechanisms (temperature, enzyme, pH, redox).

Main Results:

• Smart nanocarriers can be designed for passive or active targeting of tumor sites, minimizing drug elimination.
• Various nanocarrier types demonstrate potential for augmenting therapeutic efficacy in cancer treatment.
• Stimuli-responsive nanocarriers offer precise drug release triggered by cancer-specific microenvironments.

Conclusions:

• Smart nanocarriers represent a significant advancement in targeted cancer therapy.
• The development of novel nanocarrier designs and stimuli-responsive systems holds great promise for improving patient outcomes.
• Further research into surface decoration and stimuli-responsive mechanisms will drive the next generation of cancer nanotherapeutics.